ATMLP regulates MDVs mediated inflammation induced by radiotherapy in lung cancer
Journal of Radiation Research · 2026-11-05
DOI: 10.1093/jrr/rrag092 ↗Abstract
Abstract Lung cancer is the leading cause of cancer-related deaths worldwide, and radiotherapy, a commonly used treatment for lung cancer, is associated with a variety of complications while treating cancer, among which radiotherapy-induced pneumonia is a common complication whose underlying mechanism remains unclear and requires further investigation. To address this, cell lines with ATMLP overexpression and knockdown were created using gene editing techniques, and Western blot, immunofluorescence and trans-well co-culture were used to explore the role of mitochondria-derived vesicles (MDVs) in mediating radiotherapy-induced inflammation, as well as the effects of ATMLP, DRP-1 and PGAM5 on MDVs. Ionizing radiation promoted the expression of ATMLP and the release of ATMLP-mediated MDVs. Up-regulation of ATMLP expression led to increased levels of PGAM5 and activation of phosphorylation at the Ser616 site of DRP-1. The increased number of MDVs further promoted macrophage polarization toward the M1 phenotype. Overall, ionizing radiation induces ATMLP expression, which enhances MDVs release through the PGAM5/DRP-1 axis. This process leads to macrophage polarization toward the M1 phenotype, contributing to the inflammatory response.
EUVIMED